Selvita S.A.
Owner/Developer: Selvita S.A.
| Country: | Poland |
|---|---|
| Languages: | English, Polish |
| Url: | http://www.selvita.com |
| Contact: | https://selvita.com/contact/ |
| Contact Email: | selvita@selvita.com |
| Description: |
Selvita is a drug discovery company engaged in the research and development of breakthrough therapies primarily in the area of oncology, as well as provision of integrated drug discovery services. The company was established in 2007 and currently employs over 340 scientists, among which 30% are PhDs. Selvita offers integrated drug discovery projects helping biotech and pharma partners discover and develop new drugs. Our scientists have an extensive experience in several areas of life sciences. Selvita specializes in a broad spectrum of pharmacodynamic in vitro studies used to analyze biosimilar product's activity in comparison to adequate reference compounds. We offer assays that are able to detect even minor changes in biological response to pharmacologically active substances. EU-NETVAL member. |
| Category: | Organization |
| Channel: | Website - Audio / Video - Social media - Professional online network |
| Audience: | Industry |
| Relevance: | Replacement - Reduction |
| Purpose: | Fundamental studies - Toxicological and safety evaluation - Efficacy testing - Regulatory testing - Validation - Method development |
| Technology/Tools: | High throughput screening - Non-testing methods (in silico) - Omics - Alternative test methods (in vitro) |
Fant du det du lette etter?
Ja, jeg fant det! Nei, jeg fant det ikke!Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.
Hva lette du etter?
Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.
Kontakt oss gjerne på e-post hvis du har spørsmål.